Author pages are created from data sourced from our academic publisher partnerships and public sources.
6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: EVALUATION AND TREATMENT OF URINARY INCONTINENCE, PELVIC ORGAN PROLAPSE AND FAECAL…
Scientific report of the proceedings from the 6th International Consultation on Incontinence, (Tokyo 2016).
Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience
Study Type – Therapy (prevalence)
Incontinence in the frail elderly: Report from the 4th international consultation on incontinence
- Catherine E. DuBeau, G. Kuchel, T. Johnson Ii, Mary H. Palmer, A. Wagg
- Neurourology and urodynamics
- 1 January 2010
To summarize current knowledge on the etiology, assessment, and management of urinary incontinence (UI) in frail older persons. “Frail” here indicates a person with a clinical phenotype combining… Expand
Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada.
- A. Wagg, B. Franks, B. Ramos, T. Berner
- Canadian Urological Association journal = Journal…
- 13 October 2015
INTRODUCTION Antimuscarinics are the principal pharmacological treatment for overactive bladder (OAB), but frequently give rise to anticholinergic side effects, such as dry mouth, a factor leading to… Expand
Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
- A. Wagg, J. Wyndaele, P. Sieber
- The American journal of geriatric pharmacotherapy
- 1 March 2006
BACKGROUND Overactive bladder (OAB) syndrome is characterized by urinary frequency and urgency with or without urge incontinence, and often accompanied by nocturia. The prevalence of OAB increases… Expand
Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice.
BACKGROUND Persistence with antimuscarinic therapy in overactive bladder (OAB) is poor, but may be different for mirabegron, a β3-adrenoceptor agonist with a different adverse event profile. … Expand
Patient characteristics associated with quality of life in European women seeking treatment for urinary incontinence: results from PURE.
OBJECTIVE To investigate the association between patient characteristics and disease-specific and generic quality of life (QOL) as well as the degree of bother in women seeking treatment for urinary… Expand
Urinary incontinence in frail elderly persons: Report from the 5th International Consultation on Incontinence
Evidence based guidelines for the management of frail older persons with urinary incontinence are rare. Those produced by the International Consultation on Incontinence represent an authoritative set… Expand
Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process…
Aim: we aimed to systematically review drugs to treat lower urinary tract symptoms (LUTS) regularly used in older persons to classify appropriate and inappropriate drugs based on efficacy, safety and… Expand
Medical resource utilisation and cost of care for women seeking treatment for urinary incontinence in an outpatient setting. Examples from three countries participating in the PURE study.
OBJECTIVE To describe the medical resource use and direct costs of treatment for women with urinary incontinence (UI) in European countries. DESIGN PURE is a non-interventional, observational study… Expand